Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density

Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect

(2016) María José Ortuño et al.   NATURE MEDICINE

Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States

(2015) Andrea Singer et al.   MAYO CLINIC PROCEEDINGS

Increased Risk of Osteoporosis in Patients With Depression

(2015) Cynthia Wei-Sheng Lee et al.   MAYO CLINIC PROCEEDINGS

Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review

(2014) Marie Anne Gebara et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults

(2013) Lauren D. Garfield et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

(2013) Alize J. Ferrari et al.   PLOS MEDICINE

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

(2011) Stefano Porcelli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Variants of the Serotonin Transporter Gene, Selective Serotonin Reuptake Inhibitors, and Bone Mineral Density in Risperidone-Treated Boys

(2011) Chadi A. Calarge et al.   JOURNAL OF CLINICAL PSYCHIATRY

Potential Role for Therapies Targeting DKK1, LRP5, and Serotonin in the Treatment of Osteoporosis

(2011) Wei Zhang et al.   Current Osteoporosis Reports

Depression and Osteoporosis: A Research Synthesis with Meta-Analysis

(2010) G. Cizza et al.   HORMONE AND METABOLIC RESEARCH

Update in Serotonin and Bone

(2010) Michael Bliziotes   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM